about
neuspera medical

Empowering Patients To

change their lives

Neuspera® Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. The company’s proprietary Mid-Field Powering Technology allows devices to be significantly smaller, implanted deeper, and more reliable than other miniaturized neuromodulation technologies. The Neuspera platform will provide patients and physicians new, and potentially earlier, treatment options that are less invasive and more adaptable. These therapeutic alternatives may help patients restore their health and well-being for a better quality of life.

Our

executive team

Milton M. Morris, Ph.D.
President and CEO
+
Milton M. Morris, Ph.D.
President and CEO

Milton M. Morris, Ph.D. joined Neuspera® Medical as its President and CEO in July of 2015. Prior to Neuspera, Milton was the Sr. Vice President of Research & Development and Emerging Therapies at Cyberonics. During his 6-year tenure at Cyberonics, he established and grew an R&D organization, hiring top technical talent in disciplines from ASIC development to algorithm development to signal processing. Milton joined Cyberonics from InnerPulse, a privately held cardiology-focused start-up, where he was Director, Program Management and Operations. Prior to InnerPulse, Milton was employed by Boston Scientific Corp. During his tenure, he held several positions, including Principal Research Scientist; Director, Research & Development; Director, Marketing and Arrhythmia Franchise Leader, responsible for both the implantable pacemaker and defibrillator businesses. Milton spent 5 years developing algorithms to detect lethal arrhythmia as a Research Assistant in the Medical Computing Laboratory at the University of Michigan.

Milton is an elected member of the American Institute for Medical and Biological Engineering College of Fellows for contributions to developing and commercializing innovations in bioelectronic medicine, among other things. Milton is an inventor on 30 patents and an author on 20 peer-reviewed publications and book chapters. He holds an MBA from Kellogg School of Management, an M.S. and Ph.D. in Electrical Engineering from the University of Michigan and a B.S. in Electrical Engineering from Northwestern University.

Alexander J. Yeh, Ph.D.
Founder and Chief Technology Officer
+
Alexander J. Yeh, Ph.D.
Founder and Chief Technology Officer

Alexander J. Yeh is Founder, CTO, and Director of Neuspera® Medical Inc. His areas of specialty include wireless power transfer, neurophysiology, RFIC design, wireless communications, and semiconductor packaging.

Alex founded Neuspera to translate the work he advanced during his Ph.D. candidacy at Stanford University. He successfully developed devices and conducted experiments that demonstrated midfield power transfer to deeply implanted miniature devices in preclinical models as outlined in his dissertation, “Wireless Powering and Communications for mm-Sized Pacemakers, Sensors, Neuromodulators, And Optogenetics.” At Neuspera, this fundamental technology has been adapted to human use under his leadership.

Prior to joining Stanford, he was a researcher in communication algorithms for 60 GHz wireless systems and worked as an engineer in a startup, TagArray, developing UWB RFID products.

Alex has a M.S. and Ph.D. from Stanford University in Electrical Engineering, and has a BS in Electrical Engineering and BA in Economics from University of California – Los Angeles. He is named in over 100 patents, patent applications, and academic papers related to implantable medical devices. He also serves on the board of Greenliant Systems, Ltd, a leading global supplier of solid-state storage solutions for industrial, automotive, and medical applications.

Andrina Hougham SVP
Clinical Research, Regulatory Affairs, and Reimbursement
+
Andrina Hougham SVP
Clinical Research, Regulatory Affairs, and Reimbursement

Andrina Hougham has 30 years of medical device and pharmaceutical experience in the areas of clinical research, reimbursement, regulatory affairs, and product development. Andrina was the VP of Clinical Research, Reimbursement, and Regulatory Affairs for the Neuromodulation business at Medtronic. These functions supported the global growth of the Neuromodulation business to over $2B in revenue through innovative evidence development that drove timely, differentiated and sustainable global market access. While at Medtronic, she was also the VP of Clinical Research for the Cardiac Rhythm Disease Management organization. In addition, she led a cross-functional product development team responsible for bringing a breakthrough Cardiac Disease Management System to the marketplace and an initiative to provide healthcare to economically disadvantaged patients in Medellin, Colombia. Prior to Medtronic, Andrina developed her clinical research experience at 3M Pharmaceuticals where she worked across all phases of clinical trials on New Drug Applications to achieve product approvals in multiple therapeutic areas.

Andrina has a Masters of Healthcare Administration from the University of Minnesota and a BA in Biochemistry and Molecular Biology from the University of California at Santa Barbara.

Tim Ciciarelli
VP, Research and Development
+
Tim Ciciarelli
VP, Research and Development

Tim Ciciarelli has over 20 years of medical device R&D experience, and has spent much of that time at venture-backed start-up companies. Tim’s areas of expertise include product development, electronics and software engineering, and system design. Tim’s products have received CE mark and FDA approval through both the PMA and 510(k) process. Most recently, Tim served as the Engineering Director at Nanostim, where he helped develop the world’s first leadless pacemaker. Prior to that Tim served as the Director of Product Development for Epicor Medical, where he helped develop a novel ultrasound ablation system to treat atrial fibrillation. Both Nanostim and Epicor Medical were acquired by St. Jude Medical (now Abbott).

Tim has an M.S. in Electrical Engineering from Stanford University and a BS in Physics from the University of Virginia.

Steve Schellenberg
VP, Operations
+
Steve Schellenberg
VP, Operations

Steve Schellenberg has been in the active implantable industry since 1995. He has led operations at multiple early stage companies transitioning through to commercialization and acquisition. He was Director of Operations at Epicor Medical, and Director of Manufacturing Engineering at Spinal Modulation, both acquired by St. Jude Medical (now Abbott). Steve was also VP of Operations at Intrapace Inc. where he helped lead the development and building of operations in support of an implantable neurostimulator intended for the treatment of obesity, resulting in CE mark approval and successful OUS Clinical Trial.

Steve is an expert in electronics assembly and test, design for manufacturing, and hermetic welding. He is well versed in packaging, sterilization, and quality systems. He has built the infrastructure to support product development, regulatory approvals, clinical trials, and commercialization for multiple enterprises. Steve has a BS in Mechanical Engineering from California State University at Chico.

Our

investors

Featured

awards and milestones

Neuspera® Announced as One of the Hottest Medtech Startups of 2017
Neuspera® Wins Most Promising Startup at NeuroTech Leaders Forum 2016
Neuspera® Raises $8M to Back Tiny, Injectable Neuromodulation Technology

INTERESTED IN

joining our team?

Neuspera Medical is a dynamic, fast-paced and innovative company. We welcome individuals with a passion for improving patients’ lives to reach out to careers@neuspera.com and let us know their interests.